Other
VO2 Max
VO2 Max is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed375%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
completed
Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test
NCT07554404
completed
Estimating VO2 Max and Recovery
NCT06744582
not_yet_recruiting
Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance
NCT07516509
completednot_applicable
Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?
NCT03809793
Clinical Trials (4)
Showing 4 of 4 trials
NCT07554404
Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test
NCT06744582
Estimating VO2 Max and Recovery
NCT07516509
Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance
NCT03809793Not Applicable
Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4